Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy

Hua Liu1, Niu Tian, Istvan Arany

  • 1Department of Pediatrics, 5 P42 ES07381 , USA.

Insights

Cytochrome P450 2B1 (CYP2B1) exacerbates kidney damage in membranous nephropathy models. Inhibiting CYP2B1 protects against injury and proteinuria, highlighting its role in disease development.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Membranous nephropathy causes proteinuria and kidney dysfunction.
  • Passive Heymann nephritis models human disease, involving glomerular epithelial cell (GEC) injury via complement C5b-9.
  • The role of cytochrome P450 2B1 (CYP2B1) in this injury is unclear.

Purpose of the Study:

  • To investigate the role of CYP2B1 in complement-mediated GEC injury in passive Heymann nephritis.
  • To determine if CYP2B1 contributes to the pathogenesis of this kidney disease model.

Main Methods:

  • Overexpression and silencing of CYP2B1 in GECs.
  • Assessment of reactive oxygen species (ROS) generation, cytotoxicity, and actin cytoskeleton integrity.
  • In vivo studies in rats using the anti-Fx1A model and treatment with a CYP450 inhibitor (cimetidine).

Main Results:

  • CYP2B1 overexpression increased ROS, cytotoxicity, and actin collapse in GECs.
  • CYP2B1 silencing reduced ROS, cytotoxicity, and preserved the actin cytoskeleton and gelsolin.
  • In vivo, cimetidine inhibited ROS, reduced oxidative damage, maintained nephrin distribution, and prevented proteinuria.

Conclusions:

  • GEC CYP2B1 significantly contributes to complement C5b-9-mediated injury.
  • CYP2B1 plays a critical role in the pathogenesis of passive Heymann nephritis.
  • Targeting CYP2B1 may offer a therapeutic strategy for membranous nephropathy.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...